News | October 21, 2010

Daniel S. Berman Receives Pioneer in Medicine Award

October 21, 2010 – Daniel S. Berman, M.D., an innovator of cardiac imaging technology for 30 years, has received the Pioneer in Medicine Award from Cedars-Sinai Medical Center, its highest honor.

Berman is recognized as one of the world’s pre-eminent clinical investigators in noninvasive cardiac imaging and one of the founding fathers of nuclear cardiology. He established the largest and most extensively studied patient database in the field of cardiac imaging, analyzing information from more than 60,000 patients. He and his team developed statistical models to predict the likelihood of severe cardiac events, and, in the process, they shaped the way cardiac imaging is practiced worldwide.

He also co-directed a program bringing together scientists, programmers and cardiologists to create software that enables computers to analyze 3-D images produced by advanced imaging technologies. The totally software – which takes subjective, human interpretation out of the equation and standardizes methodology – has been licensed and distributed to virtually all of the imaging technology manufacturers and is considered the standard in the field.

As a mentor and educator, Berman has had a major influence on the careers of countless medical students, cardiologists, radiologists, internists and technologists. He has held prominent leadership positions in virtually all of the national professional societies devoted to cardiovascular medicine and cardiovascular imaging. Throughout his career, he has served on a number of medical journal boards, and he has helped write guidelines for such organizations as the American College of Cardiology, the American Heart Association, the American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.

Berman also has published more than 350 articles in peer-reviewed journals, written 110 book chapters, and edited or co-edited five books.

Recruited 33 years ago to serve as director of nuclear cardiology, Berman quickly recognized the importance of “multimodality cardiac imaging” – the use of various technologies to establish an accurate picture of the heart and its function.

The Pioneer in Medicine Award was presented by Steven Galen, M.D., Vice Chief of Staff, and chair of the Pioneer in Medicine selection panel and John D. Friedman, M.D., chief of Outpatient Cardiac Imaging.

The award is presented to a member of Cedars-Sinai’s medical staff who meets numerous criteria and has made clinical and research contributions recognized at Cedars-Sinai and in the national or international medical communities. The recipient must have made a major contribution to the Medical Center, be or have been involved in research, have been published in national or international peer-reviewed journals, be a teacher and a positive role model, be an innovator or have changed the medical world around him or her, and have been a physician at the Medical Center during a major part of his or her career.

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a
Sponsored Content | Videos | Clinical Decision Support | June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Dual-Agent PET/MR With Time of Flight Detects More Cancer

Tc-99m MDP bone scan (left) is negative for osseous lesions. NaF/FDG PET/MRI (right and second slide) confirms absence of bone metastases, but shows liver metastases. Image courtesy of Stanford University.

News | PET-MRI | June 20, 2017
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (...
Combined Optical and Molecular Imaging Could Guide Breast-Conserving Surgery

WLE specimen from a patient with a grade 3, ER-/HER2-, no special type (NST) carcinoma. (A) Cerenkov image; (B) Grey-scale photographic image overlaid with Cerenkov signal. An increased signal from the tumor is visible (white arrows); mean radiance is 871 ± 131 photons/s/cm2/sr, mean TBR is 3.22. Both surgeons measured the posterior margin (outlined in blue) as 2 mm (small arrow); a cavity shaving would have been performed if the image had been available intraoperatively. The medial margin (outlined in green) measured >5 mm by both surgeons. Pathology ink prevented assessing the lateral margin; a phosphorescent signal is visible (open arrows). (C) Specimen radiography image. The absence of one surgical clip to mark the anterior margin, and the odd position of the superior margin clip (white arrow) prevented reliable margin assessment. (D) Combined histopathology image from two adjacent pathology slides on which the posterior margin (bottom of image) and part of the primary tumor are visible (open arrows). The distance from the posterior margin measured 3 mm microscopically (double arrow). The medial margin is > 5 mm (not present in image). Credit: A. D. Purushotham, M.D., King’s College London, UK

News | Nuclear Imaging | June 20, 2017
June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage...
Overlay Init